BioXcel Therapeutics (BTAI) Ends The Year On High Note, Stock Up Over 300%

Shares of BioXcel Therapeutics Inc. (BTAI) closed Tuesday, the last trading day of 2019, at $14.61, up a whopping 338% in the year.

from RTT - Biotech https://ift.tt/35joUAx
via IFTTT

Activity May Be Subdued On Final Trading Day Of 2019

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2QbbtOE
via IFTTT

Universal Music sells stake to Chinese giant Tencent

Owner Vivendi to offload 10% stake worth €3bn with more deals likely to cash in on music revival

Universal Music Group, the home of stars including Taylor Swift, Lady Gaga and The Beatles, has sold a 10% stake to a consortium led by Chinese tech giant Tencent in a deal valuing the world’s largest music company at €30bn (€25bn).

UMG’s parent company, Vivendi, which is controlled by the French billionaire Vincent Bolloré, has also agreed that the Tencent-led consortium has the option to buy another stake of up to 10% at the same price by 15 January 2021.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2QbHAxt

EyeGate Pharma (EYEG) Has Caught Investors' Eyes, Stock Up 300% In 3 Months

Shares of EyeGate Pharmaceuticals Inc. (EYEG), which closed at a new 52-week high of $12.20 on Monday, have gained an impressive 312% in the last three months.

from RTT - Biotech https://ift.tt/35bgIC3
via IFTTT

ERYTECH Pharma (ERYP) Up 40% This Month, What Next?

French biotech ERYTECH Pharma S.A. (ERYP) has gained nearly 40% this month as the Company progresses with its lead product candidate Eryaspase, which is based on its proprietary ERYCAPS platform.

from RTT - Biotech https://ift.tt/39u8Kre
via IFTTT

Biotech Stocks Facing FDA Decision In January 2020

A total of 48 novel drugs and biologics received FDA approval in 2019. Let's take a look at the FDA calendar of January 2020.

from RTT - Biotech https://ift.tt/2ZBHjqK
via IFTTT

ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed

Today's Daily Dose brings you news about Aridis Pharma's collaboration with privately-held Mapp Biopharmaceutical; FDA approval for AZN/MRK's Lynparza for yet another indication; Axsome Therapeutics' continuing momentum; Sol-Gel's acne trial results; update on X4 Pharmaceuticals' Mavorixafor, and jail term for the Chinese scientist He Jiankui.

from RTT - Biotech https://ift.tt/36bXY6V
via IFTTT

Futures Pointing To Modestly Higher Open On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Monday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2sxxyOj
via IFTTT

Dr. Reddy's Launches Generic Equivalent Of Nitropress Injection

Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Sodium Nitroprusside Injection single-dose Vial, the therapeutic generic equivalent of Nitropress Injection, 50 mg/2mL vial. Sodium nitroprusside is indicated for the immediate reduction of blood pressure of patients in hypertensive crises. The company's FDA approved Sodium Nitroprusside Injection is available in the U.S. market in single-dose 50 mg/2 mL (25 mg/mL) vials.

from RTT - Biotech https://ift.tt/2u47kDz
via IFTTT

Cece's Ramen Noodles Recalled For Listeria Concerns

Veggie Noodle Co., LLC recalled its Cece's Veggie Co. brand Ramen noodles for fear of Listeria monocytogenes contamination. The recall involves all expiration dates of Cece's brand Fresh Veggie Ramen with Chicken Broth, which includes separately packaged egg - branded Peckish. The action was due to a recall by its egg supplier Almark Foods following recent Listeria illness outbreak.

from RTT - Biotech https://ift.tt/37vWDIv
via IFTTT

Avenue Therapeutics (ATXI) Hits All-time High, Up 56% So Far This Month

Shares of Avenue Therapeutics Inc. (ATXI), which closed at an all-time high of $9.22, have gained 56% so far this month.

from RTT - Biotech https://ift.tt/2MF3yqC
via IFTTT

What Awaits Mereo BioPharma (MREO) In 2020?

Mereo BioPharma Group plc (MREO) has gained over 160% in the last three trading days as it gears up for a couple of important clinical trial catalysts in the coming year.

from RTT - Biotech https://ift.tt/2QyLuj9
via IFTTT

Iterum Therapeutics: One Down, Two To Go

Iterum Therapeutics plc (ITRM) has two clinical trial catalysts to watch out for in the first quarter of 2020.

from RTT - Biotech https://ift.tt/2MEzICC
via IFTTT

U.S. Stocks May Extend Recent March To Record Highs

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to see further upside after climbing to new record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2ZrHLIh
via IFTTT

Ascendis Pharma (ASND) Keeps Growing...

Ascendis Pharma A/S (ASND) closed Thursday's trading at an all-time high of $136.83 as it gears up for some important clinical and regulatory catalysts in the coming months.

from RTT - Biotech https://ift.tt/35Z5GkM
via IFTTT

Verona Pharma (VRNA) Jumps 45% On Looming Trial Data

Shares of UK-based Verona Pharma plc (VRNA) soared nearly 45% on Thursday and added another 23% in extended trading as the Company awaits data from its phase IIb dose-ranging study evaluating the effect of nebulized Ensifentrine as an add-on to treatment with a long-acting bronchodilator in patients with moderate-to-severe chronic obstructive pulmonary disease.

from RTT - Biotech https://ift.tt/2Q1Pzgs
via IFTTT

Aprea Therapeutics (APRE) Marches Ahead, Up 130% In Nearly 3 Months

Aprea Therapeutics Inc. (APRE), which closed at a new high of $47.44 on Thursday, gaining nearly 20%, has more than doubled in value since its IPO on October 3, 2019.

from RTT - Biotech https://ift.tt/2tWnoar
via IFTTT

Oncolytics Biotech (ONCY) Hits New 52-week High, What's The Buzz?

Shares of Oncolytics Biotech Inc. (ONCY) jumped more than 50% to touch a 52-week high of $2.91 in intraday trading on Thursday, before closing at $2.82.

from RTT - Biotech https://ift.tt/2tMyIpl
via IFTTT

Markets May Continue To Benefit From Recent Upward Momentum

The major U.S. index futures are pointing to a modestly higher opening on Thursday as some traders return to their desks following the holiday on Wednesday.

from RTT - Market Analysis https://ift.tt/2rpYGOC
via IFTTT

Futures Pointing To Modest Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher open on Tuesday, with stocks likely to extend a recent upward trend.

from RTT - Market Analysis https://ift.tt/2QfSOjr
via IFTTT

Mavidon Recalls Medical Devices For Burkholderia Cepacia Concerns

Mavidon is recalling all lots of medical device products manufactured at its facility with immediate effect due to contamination with Burkholderia cepacia, a multi-drug resistant pathogenic microorganism. The recall, with the knowledge of the FDA, involves LemonPrep, PediaPrep and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions, Collodion removers.

from RTT - Biotech https://ift.tt/2QdOsJO
via IFTTT

FDA Approves New Treatment For Migraine In Adults

Adults suffering with acute and immediate attack of migraine now have a new treatment option with the approval of Ubrelvy (ubrogepant) by the U.S. Food and Drug Administration. Allergan USA, Inc.'s Ubrelvy tablets are approved to treat migraine with or without aura - a sensory phenomenon or visual disturbance, in adults. However, it is not indicated for the preventive treatment of migraine.

from RTT - Biotech https://ift.tt/2Mq5HGs
via IFTTT

BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today

Shares of BridgeBio Pharma Inc. (BBIO) have gained 60% so far in December, as the Company gears up for some important events in the months ahead.

from RTT - Biotech https://ift.tt/2Zuoki5
via IFTTT

MBOT To Unveil 1st Disposable Robot For Endovascular Procedures, Stock Up 77%

Shares of medical device company Microbot Medical Inc. (MBOT) jumped more than 70% on Monday after the Company announced that it would be unveiling LIBERTY, the world's first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures, on January 13, 2020, in San Francisco.

from RTT - Biotech https://ift.tt/34S2V3p
via IFTTT

Phathom Pharma Climbs 45% In 4 Days As Lead Drug Advances Into Phase III

Shares of Phathom Pharmaceuticals Inc. (PHAT) have gained an impressive 45% over the last four trading days, thanks to the progress in the development of its lead and sole drug Vonoprazan.

from RTT - Biotech https://ift.tt/2Sm9p83
via IFTTT

ACST On Watch, ITCI Jumps 250% On Trial Data, CVM Slumps, FDA Nod For AGN

Today's Daily Dose brings you news about FDA approvals of Allergan and Intra-Cellular Therapies; blockbuster deal signed between Roche and Sarepta; and positive phase III trial results of Progenics Pharmaceuticals, among others.

from RTT - Biotech https://ift.tt/2PP3Vkq
via IFTTT

Cobham’s US buyer vows to keep UK jobs and investment

Advent International also commits to British HQ, which employs about 1,700 staff

The new US owner of the UK defence company Cobham has pledged to keep jobs and investment in Britain as the government faces increasing criticism for allowing the £4bn takeover to go ahead.

The world-leading expert in air-to-air refuelling said its private-equity buyer, Advent International, had committed to maintaining a UK headquarters and to continue funding research and development at its Dorset offices. It has also vowed to keep using the company’s name, which references Sir Alan Cobham who founded the firm in 1934.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2QgyBKb

Positive Trade News May Generate Continued Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to extend the upward trend seen in recent sessions.

from RTT - Market Analysis https://ift.tt/2PT5VIB
via IFTTT

Euro Tech Holdings Post Loss In H1 - Quick Facts

Euro Tech Holdings Co. Ltd. (CLWT) on Monday reported in its unaudited financial results for the six months ended June 30, 2019 a net loss of about $280,000 for the first-half of 2019, compared to net profit of about $878,000 in the prior-year period, which included a non-recurrent net gain on disposal of an affiliate of approximately $1.52 million.

from RTT - Earnings https://ift.tt/2EM0O6v
via IFTTT

Healthcare IPOs That Disappointed Investors In 2019

As we ready to step into 2020, it's time to take a look at some of the healthcare IPOs that failed to impress investors in 2019. As of now, 76 healthcare companies have made their debut on the bourses in 2019 versus more than 80 in the previous year and 50 in 2017.

from RTT - Biotech https://ift.tt/2sSYWWQ
via IFTTT

Eloxx Pharma Up 45% So Far In Dec., What Next?

Shares of Eloxx Pharmaceuticals Inc. (ELOX) are up over 45% so far this month as it awaits the phase II topline data of its lead drug candidate ELX-02 in nephropathic cystinosis.

from RTT - Biotech https://ift.tt/35PrTSb
via IFTTT

IVERIC Hits New 52-Week High, Stock Up 690% In 2 Months

Shares of IVERIC bio Inc. (ISEE), formerly Ophthotech Corp., have climbed more than 690% in just two months, thanks to the encouraging Zimura clinical trial results in geographic atrophy secondary to dry age-related macular degeneration.

from RTT - Biotech https://ift.tt/2sb9oc8
via IFTTT

Axsome Therapeutics' Awesome Journey From $3 To $100, What Next?

Shares of Axsome Therapeutics Inc. (AXSM) closed Friday's trading at $100.67, a gain of 115% in just five trading days. This is for the first time that the stock's closing price has hit the $100 mark. On Thursday, the stock had briefly touched an intraday high of $104.98, only to close at $95.30.

from RTT - Biotech https://ift.tt/2sMqA7U
via IFTTT

Upward Momentum May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Friday, with stocks likely to see further upside after climbing to new record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2MgJDhD
via IFTTT

FDA Grants Approval For Merck's Ebola Vaccine Ervebo - Quick Facts

The U.S. Food and Drug Administration announced Friday the approval of Merck & Co., Inc.'s (MRK) Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. Cases of EVD are very rare in the U.S.

from RTT - Biotech https://ift.tt/2s4i2sU
via IFTTT

Magic Mushroom Clears Safety Hurdle In Largest Controlled Study To Date

Recently, in a phase I placebo-controlled trial conducted by King's College London, Psilocybin was found to be well-tolerated when administered to healthy adult volunteers, and had no negative effects on cognitive and emotional functioning.

from RTT - Biotech https://ift.tt/2rWOhdM
via IFTTT

Quest Diagnostics - Growing & Gaining

Shares of Quest Diagnostics Incorporated (DGX), which touched a 52-week high of $108.95 in intraday trading yesterday, are up nearly 35 percent year-to-date.

from RTT - Biotech https://ift.tt/34GgTVQ
via IFTTT

PhaseBio Pharma Up 82% In 5 Days - What's The Buzz?

Shares of PhaseBio Pharmaceuticals Inc. (PHAS) have returned an impressive 82% over the last five trading days.

from RTT - Biotech https://ift.tt/2ttI895
via IFTTT

ENDRA Life Soars 35% As It Moves Towards Getting CE Mark For TAEUS Liver Device

ENDRA Life Sciences Inc. (NDRA) achieved a major step toward commercialization of TAEUS FLIP device on Thursday by submitting its Technical File for CE Mark review to its Notified Body.

from RTT - Biotech https://ift.tt/35HTsfY
via IFTTT

PLx Pharma Up 210% YTD, What Next?

Shares of PLx Pharma Inc. (PLXP) climbed more than 41% on Thursday, as the Company gears up to submit a supplemental new drug application to the FDA for Vazalore 81mg by the end of this year.

from RTT - Biotech https://ift.tt/35HSv7v
via IFTTT

FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed

Today's Daily Dose brings you news about FDA approval of Bausch Health's acne drug; licensing deal between Catalyst Biosciences and Biogen; disappointing MDD trial results of Minerva and Urogen's upcoming regulatory catalyst.

from RTT - Biotech https://ift.tt/2Ey0WGH
via IFTTT

Just Eat takeover battle heats up as rivals make new bids

Dutch takeaway company and offshoot of South African group up offers for food delivery firm

The battle for control of Just Eat has intensified after fresh rival bids for the UK food delivery business.

Takeaway.com of the Netherlands upped its all-share merger offer to a deal worth 916p a share. The offer, which would create one of the biggest food delivery groups in the world, values Just Eat at nearly £6.3bn, up from a previous bid in the summer that valued the company’s shares at 731p each.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/34EvelE

Caution May Continue To Prevail On Wall Street

The major U.S. index futures are pointing to a roughly flat opening on Thursday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2PZ6ori
via IFTTT

Conagra Brands Trims FY20 Adj. EPS, Net Sales Outlook - Quick Facts

While reporting financial results for the second quarter on Thursday, Conagra Brands, Inc. (CAG) trimmed its adjusted earnings and net sales guidance range for the full-year 2020, primarily to reflect the divestiture of the DSD snacks business and the exit of its private label peanut butter business. The updated guidance includes the expected results from the Lender's business for the full fiscal year.

from RTT - Earnings https://ift.tt/2s5TsIj
via IFTTT

FactSet Affirms FY20 Outlook - Quick Facts

While reporting financial results for the first quarter and fiscal 2020 on Thursday, FactSet Research Systems Inc. (FDS) affirmed its earnings and revenue outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/2PEuNDq
via IFTTT

Rite Aid Narrows FY20 Adj. EPS Outlook Range - Quick Facts

While reporting financial results for the third quarter on Thursday, drugstore chain Rite Aid Corp. (RAD) narrowed its earnings outlook for the full-year 2020, while maintaining annual revenue and same store sales guidance.

from RTT - Earnings https://ift.tt/2MbZ2zx
via IFTTT

Accenture Q1 Results Beat Estimates; Lifts Low End Of FY Outlook Range

Accenture Plc (ACN) on Thursday reported net income for the first quarter of $1.38 billion, a 6 percent increase from $1.29 billion in the same period last year. Earnings per share for the quarter rose to $2.09 from $1.96 in the prior-year period.

from RTT - Earnings https://ift.tt/2McsEwV
via IFTTT

Darden Reaffirms FY20 Outlook; Declares Qtly Dividend - Quick Facts

While reporting financial results for the second quarter on Thursday, Darden Restaurants, Inc. (DRI) again reaffirmed its financial outlook for the full-year 2020, which is a 53-week fiscal year. The outlook includes the impact of the additional week.

from RTT - Earnings https://ift.tt/2EvfE1b
via IFTTT

Mirum Pharma Surges 190% In 3 Days

Mirum Pharmaceuticals Inc. (MIRM), which topped the list of Biggest Percentage Price Gainers among healthcare stocks on Monday, topped the list again on Wednesday - gaining 44% to close at an all-time high of $23.76, before touching an intraday high $27.28.

from RTT - Biotech https://ift.tt/2Z7gOcK
via IFTTT

Futures Pointing To Another Uptick On Wall Street

The major U.S. index futures are pointing to a modestly higher opening on Wednesday, with stocks likely to show another uptick.

from RTT - Market Analysis https://ift.tt/35A7vnY
via IFTTT

General Mills Q2 Profit Beats Estimates, Organic Sales Up 1%; Affirms Outlook

General Mills (GIS) reported that its second-quarter adjusted earnings per share improved 11 percent year-on-year in constant currency to $0.95. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $0.88, for the quarter. Analysts' estimates typically exclude special items. Adjusted operating profit was $813 million, up 7 percent in constant currency, primarily driven by higher adjusted gross margin and lower consumer promotional expense, partially offset by higher media expense.

from RTT - Earnings https://ift.tt/2sIg6pS
via IFTTT

Peugeot and Fiat Chrysler agree terms of £38bn merger

Relief for PSA’s Vauxhall workers in Ellesmere Port as there will be no factory closures

Peugeot and Fiat Chrysler have agreed terms of a £38bn (€34bn) merger that will create the world’s fourth largest carmaker, the companies announced on Wednesday.

The two parent companies, PSA Group and Fiat Chrysler Automobiles, confirmed there will be no plant closures as part of €3.7bn in cost savings from the merger, a key concern for more than 1,000 workers at PSA’s Vauxhall factory in Ellesmere Port.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2EvPefw

Flexion Awaits FDA Word On Revised Zilretta Label

Shares of Flexion Therapeutics Inc. (FLXN) are down nearly 14 percent from their 52-week high of $21.39, recorded as recently as last week, and trade around $18.

from RTT - Biotech https://ift.tt/2Py3R8I
via IFTTT

Top Gainers: VIE To Face FDA In June, NLTX Up 65% In Dec., Be AWARE Of ONCY

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2M749kD
via IFTTT

Traders Looking For Next Catalyst To Drive The Markets

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday, with stocks likely to show a lack of direction after climbing to record highs in the previous session.

from RTT - Market Analysis https://ift.tt/2PTSqab
via IFTTT

Jabil Boosts FY20 Core EPS Outlook: Guides Q2 In Line With View - Quick Facts

While reporting preliminary, unaudited financial results for its first quarter of fiscal 2020 on Tuesday, Jabil, Inc. (JBL) provided earnings and revenue guidance for the second quarter in line with analysts' estimates. The company also raised its core earnings outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/36NXIL1
via IFTTT

Worthington Industries Q2 Results Top Estimates - Quick Facts

Worthington Industries, Inc. (WOR) reported Tuesday that net earnings for the second quarter of fiscal 2020 grew to $52.1 million or $0.93 per share from $34.0 million or $0.57 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/38M2Jpf
via IFTTT

Drugs That Missed Key Goals In Phase III Trials

In this article, we present some of the phase III clinical trial failures that made major news headlines in 2019. These were compounds on which companies had bet big, with patients and the medical community having had high hopes.

from RTT - Biotech https://ift.tt/2szfrHp
via IFTTT

Top Gainers: CLSD Making A Second Try, RLMD Abuzz, Busy Year Ahead For BTAI

The following are some of the stocks that gained the most in the healthcare sector on Monday.

from RTT - Biotech https://ift.tt/2RWJUtw
via IFTTT

AXSM Again Proves It Is Awesome, MIRM Leaps To $22, WVE Doesn't Go The Distance

Today's Daily Dose brings you news about Akero's NASH study update; Axsome Therapeutics' major depressive disorder trial results; CEL-SCI's near-term catalyst; BioMarin's promising results of achondroplasia drug candidate; Wave Life Sciences decision to discontinue the development of DMD drug candidate and more.

from RTT - Biotech https://ift.tt/2rJBQSx
via IFTTT

Amneal Pharma (AMRX) Focusing On 2020 & Beyond

Shares of Amneal Pharmaceuticals Inc. (AMRX) have nearly doubled over the last 28 trading days and trade around $5.40.

from RTT - Biotech https://ift.tt/2PUbN2X
via IFTTT

Did Stryker (SYK) Catch Your Eye?

Shares of Stryker Corp. (SYK), a medical technology company, are up in pre-market trading today.

from RTT - Biotech https://ift.tt/2EkCJ6w
via IFTTT

Positive Sentiment May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to extend the advance seen last week.

from RTT - Market Analysis https://ift.tt/38JnOka
via IFTTT

Will These Pharma Stocks Soar Or Swoon This Month? (ACER, ACST, ADMS, SLGL)

Listed below are some of the pharma companies whose phase III trial results might be reported this month.

from RTT - Biotech https://ift.tt/2tnqdkv
via IFTTT

British Steel bid still on, insists Chinese firm Jingye

Jitters in Whitehall grow over any further delay with government spending £1m a day to keep business alive

The Chinese firm poised to buy British Steel has denied the deal is in danger of collapse, amid concern that any further delay in the already lengthy sale process will make the business less attractive to alternative buyers.

Jingye, an industrial giant founded by a former Communist party official, agreed to buy British Steel in early November after an earlier round of talks with the pension fund of the Turkish military broke down.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2PMyc2b

Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

2019 saw more than 25 acquisition deals being executed in the biotech sector, of which 14 were billion-dollar deals. Bristol-Myers Squibb (BMY) acquiring Celgene for $74 billion in January remains the most expensive acquisition of this year.

from RTT - Biotech https://ift.tt/2PmA2HX
via IFTTT

Futures Pointing To Higher Open Ahead Of Chinese Press Conference

The major U.S. index futures are currently pointing to a higher opening on Friday following the strong upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/2EgNBT2
via IFTTT

First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges

Today's Daily Dose brings you news about the sweet surprise for Sarepta; spike in Amneal Pharma's stock price; Oncternal Therapeutics' breast cancer trial results and Centene's 2020 outlook.

from RTT - Biotech https://ift.tt/35hpqj9
via IFTTT

Home Depot Blames Opioid Crisis For Recent Rise In Store Thefts

Home Depot has blamed the nation's opioid crisis for the recent surge in theft at its stores, reports said. The home improvement retailer made the claim at an analyst and investor conference on Wednesday saying it expects the theft, which retailers call shrink, to narrow its operating margin for the next year. The opioid crisis in the U.S. is growing at an alarming rate.

from RTT - Earnings https://ift.tt/34dtq2W
via IFTTT

Stock Alert: What's The Buzz About MEDNAX (MD)?

Shares of MEDNAX Inc. (MD) have climbed over 5% in the last 4 trading days.

from RTT - Biotech https://ift.tt/38pTTgO
via IFTTT

Lingering Uncertainty About Trade Deal May Weigh On Wall Street

The major U.S. index futures are pointing to a modestly lower opening on Thursday following the uptick seen in the previous session.

from RTT - Market Analysis https://ift.tt/2rEjnXi
via IFTTT

Healthcare IPOs That Delivered Solid Returns In 2019

2020 will be upon us soon. It's time to take stock of some of the US healthcare IPOs that rewarded investors in 2019.

from RTT - Biotech https://ift.tt/2EeKVFa
via IFTTT

GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch

Today's Daily Dose brings you news about Puma Biotech's SUMMIT basket trial results; TransEnterix' reverse stock split; Seattle Genetics' pivotal HER2CLIMB study and the latest update on Intec/Novartis deal.

from RTT - Biotech https://ift.tt/2qFycs2
via IFTTT

Looming Fed Announcement May Lead To Choppy Trading On Wall Street

The major U.S. index futures are pointing to a mixed opening on Wednesday, with stocks likely to extend the choppy trading seen in the previous session.

from RTT - Market Analysis https://ift.tt/2t91PTB
via IFTTT

American Eagle Guides Q4 Adj. EPS Below View - Quick Facts

While reporting financial results for the third quarter on Wednesday, specialty retailer American Eagle Outfitters, Inc. (AEO) provided earnings and comparable sales growth guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/36u5gmh
via IFTTT

Children's Place Slashes FY19 Outlook, Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Wednesday, children's specialty apparel retailer The Children's Place, Inc. (PLCE) provided adjusted earnings and net sales guidance for the fourth quarter and slashed outlook for the full-year 2019.

from RTT - Earnings https://ift.tt/2YNsT6N
via IFTTT

JetBlue Airways November Traffic, Capacity Rise; Load Factor Declines

JetBlue Airways Corp. (JBLU) reported Wednesday its preliminary traffic results for November 2019. Traffic in November increased 3.7 percent from the year-ago period, on a capacity increase of 7.1 percent.

from RTT - Earnings https://ift.tt/2Pyu9q2
via IFTTT

United Natural Foods Reaffirms FY20 Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, United Natural Foods, Inc. (UNFI) reaffirmed its adjusted earnings and net sales guidance for the full year 2020.

from RTT - Earnings https://ift.tt/38qFNMc
via IFTTT

Photronics Guides Q1 EPS, Revenues Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Photronics, Inc. (PLAB) provided earnings and revenue guidance for the first quarter of fiscal 2020, above analysts' estimates.

from RTT - Earnings https://ift.tt/2PDdBNF
via IFTTT

GRTS To Report GRANITE, SLATE Early Phase I Immunogenicity Data On Dec.12

Shares of Gritstone Oncology Inc. (GRTS), a clinical-stage biotechnology company, have rallied 26 percent so far this month in the run-up to the presentation at the European Society for Medical Oncology's Immuno-Oncology Congress (ESMO-IO) on December 12, 2019.

from RTT - Biotech https://ift.tt/2YACYDM
via IFTTT

FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

Today's Daily Dose brings you news about the FDA panel's vote on Correvio Pharma's anti-arrhythmic drug Brinavess; the near-term catalyst of Eloxx Pharma; the phase III trial results of Iterum's Sulopenem in the treatment of complicated intra-abdominal infections, and Xeris Pharma's phase II study results of ready-to-use (RTU) glucagon.

from RTT - Biotech https://ift.tt/38lrJ6N
via IFTTT

Report Of Tariff Delay May Lead To Initial Strength On Wall Street

The major U.S. index futures have recently turned positive and are currently pointing to a higher open for the markets on Tuesday.

from RTT - Market Analysis https://ift.tt/2sZsP7P
via IFTTT

QTS Realty Trust - So Far, So Good

Shares of QTS Realty Trust Inc. (QTS), a US-based data center operator, are up 48 percent year-to-date.

from RTT - Earnings https://ift.tt/2P54Htc
via IFTTT

APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

Today's Daily Dose brings you news about Aurinia Pharma's secondary offering; Aptose Biosciences' early clinical data of CG-806 and APTO-253; the proposed reverse stock split of Protalix BioTherapeutics and Gilead's path forward for KTE-X19 in the treatment for relapsed or refractory mantle cell lymphoma.

from RTT - Biotech https://ift.tt/33ZRkPe
via IFTTT

Top Gainers: THOR Acquired, FTSV Up On Magrolimab Data, Investors Believe FATE

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2Yy0tNF
via IFTTT

Had You Invested In ArQule (ARQL) In June,...

Shares of ArQule Inc. (ARQL) are currently up over 100 percent, trading at $19.66, as the Company is all set to be acquired by Merck Inc. (MRK).

from RTT - Biotech https://ift.tt/2LG01rI
via IFTTT

Futures Pointing To Modestly Lower Open On Wall Street

The major U.S. index futures are currently pointing to a modestly lower opening on Monday following the upward trend seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2YyzUb7
via IFTTT

Globus Medical's (GMED) Got A Spine...

Shares of Globus Medical Inc. (GMED) closed at an all-time high of $57.18 on Friday (Dec.6), and are up 32 percent year-to-date.

from RTT - Biotech https://ift.tt/2qxri8c
via IFTTT

At The ASH 2019 Annual Meeting: AXLA, CBMG, SRRA, EPZM, STOK...

The following are some of the companies that presented new/updated trial data of their investigational drug candidates at the 61st Annual Meeting of the American Society of Hematology (ASH) on Saturday.

from RTT - Biotech https://ift.tt/33X2apf
via IFTTT

What Awaits Obseva (OBSV) On Monday?

Obseva SA (OBSV), a specialty biopharmaceutical company operating in the field of women's health and reproductive medicine, awaits a key catalyst on Monday.

from RTT - Biotech https://ift.tt/2sVYoQd
via IFTTT

Stronger Than Expected Jobs Data May Spark Early Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Friday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2RBD3G3
via IFTTT

Genesco Raises Full Year Outlook; Records 37% Increase In Q3 Adj. EPS

Genesco Inc. (GCO) announced, for fiscal 2020, the company now expects adjusted earnings per share from continuing operations in the range of $4.10 to $4.40 with an expectation that earnings per share for the year will be near the mid-point of the range. This an increase from the previous guidance range of $3.80 to $4.20. Comparable sales are anticipated to be up 2 percent to 3 percent, for the fiscal year. Analysts polled by Thomson Reuters expect the company to report profit per share of $4.05. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2rbPqhc
via IFTTT

DOMO, DOCU, ULTA, ZUMZ On The Rise Following Earnings Results

We are featuring some stocks which climbed after-hours Thursday following the companies reported encouraging earnings results

from RTT - Earnings https://ift.tt/33WUqDo
via IFTTT

Hovnanian Enterprises Revenue Rises 16%, Stock Up

Shares of Hovnanian Enterprises Inc. (HOV), are on the run, after the homebuilder reported a 16% revenue growth and a 16.7% increase in consolidated deliveries for the fourth quarter of fiscal 2019. However, the Company incurred a loss in the fiscal fourth quarter compared to a profit in the year-ago quarter.

from RTT - Earnings https://ift.tt/2Lqs3qK
via IFTTT

Express Stock Up Over 20%

Shares of Express Inc. (EXPR), a fashion apparel retailer, are currently up over 20%, following better-than-expected topline and revenue for the third quarter, and upbeat earnings outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2rk7cyB
via IFTTT

RH Hits New High On Strong Q3 Results, Upbeat Outlook

Shares of luxury furnishing retailer RH, formerly Restoration Hardware, touched a new high of $225, and are currently trading at $$223.48, thanks to record third quarter results and upbeat fiscal 2019 guidance.

from RTT - Earnings https://ift.tt/2LnWMET
via IFTTT

Aston Martin shares accelerate on talk of bid by F1 billionaire

Lawrence Stroll, owner of Formula One team Racing point, seeking large stake

Shares in Aston Martin have surged on reports that the billionaire owner of a Formula One racing team is preparing to bid for a significant stake in the luxury carmaker.

Lawrence Stroll, the owner of Racing Point, is leading a consortium that is considering a stake in the British firm, according to Autocar.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2rhRXGy

Kroger Confirms FY19, FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Kroger Co. (KR) confirmed adjusted earnings and identical sales growth guidance for the full-year 2019 and 2020.

from RTT - Earnings https://ift.tt/2rVqfzk
via IFTTT

Upward Momentum May Make Resurgence On Wall Street

The major U.S. index futures are pointing to a higher opening on Thursday, with stocks likely to add to the gains posted in the previous session.

from RTT - Market Analysis https://ift.tt/38bipCo
via IFTTT

Patterson Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Thursday, Patterson Companies Inc. (PDCO) raised its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/2DMXQxZ
via IFTTT

Dollar General Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Dollar General Corp. (DG) raised its earnings, adjusted earnings and sales growth guidance for the full-year 2019, based on the performance through the first three quarters of 2019 and outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2YjCku6
via IFTTT

Bausch Health (BHC) Hits A New High, What Next?

Shares of Bausch Health Companies Inc. (BHC) (BHC.TO), which are up 55 percent year-to-date, closed at an all-time high of $28.68 yesterday.

from RTT - Biotech https://ift.tt/2rivQzD
via IFTTT

AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce

Today's Daily Dose brings you news about the layoff in Allena Pharma; the positive phase III trial results of Aurinia Pharma's lupus drug; stock offerings of Millendo Therapeutics and Relmada Therapeutics.

from RTT - Biotech https://ift.tt/33TqKXU
via IFTTT

Today's Top Gainers: PTGX Bounces Back, ALLK Abuzz, AVXL On The Move...

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/386ierV
via IFTTT

Upbeat Report On Trade Talks May Inspire Bargain Hunting

The major U.S. index futures are pointing to a higher opening on Wednesday following the notable pullback seen over the course of the three previous sessions.

from RTT - Market Analysis https://ift.tt/2DH6ePI
via IFTTT

Campbell Soup Backs FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter of fiscal 2020 on Wednesday, Campbell Soup Co. (CPB) maintained its adjusted earnings and organic sales growth guidance for the full-year 2020, but lowered net sales growth guidance to reflect the impact of the sale of European Chips Business.

from RTT - Earnings https://ift.tt/35XHI8Q
via IFTTT

National Bank Boosts Qtly Dividend 4% - Quick Facts

National Bank of Canada (NA.TO) announced Wednesday that it's Board of Directors a 4 percent higher quarterly dividend of $0.71 per common share for the quarter ending January 31, 2020. This dividend is payable on February 1, 2020 to common shareholders of record on December 30, 2019.

from RTT - Earnings https://ift.tt/363kgqZ
via IFTTT

Healthcare Stocks That Plunged To New Lows (PTGX, TRPX, MTP...)

We are featuring some stocks whose value dropped to new low year-to-date.

from RTT - Biotech https://ift.tt/3847dHE
via IFTTT

ARDX Jumps On PHREEDOM Data, AXSM Is Awesome, CARA On Watch

Today's Daily Dose brings you news about Ardelyx' PHREEDOM trial results; narcolepsy trial results of Axsome; TRANSCEND trial results of Protagonist Therapeutics and FDA approval of Roche's (RHHBY.OB) Tecentriq for yet another indication.

from RTT - Biotech https://ift.tt/2ONy4jw
via IFTTT

Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2RecVkd
via IFTTT

The IFS raises a far better question on Labour's renationalisation plans | Nils Pratley

Key issue is how well assets such as railways and energy would run under public ownership, not the cost

The Institute for Fiscal Studies is asking the right question about Labour’s nationalisation plans. The key issue is how well the assets would be run under public ownership. What is the party hoping to achieve that could not be done via smarter regulation?

This part of the debate has been obscured by endless quarrels over how much it would cost to nationalise rail, mail, water, energy and BT Openreach. On the cost score, the IFS report merely offered a factual two-part answer, one of which was necessarily imprecise.

Related: IFS warns Labour renationalisation may delay low-carbon economy

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2LjRGtD

Trump Comments About Trade Deal May Spark Initial Sell-Off On Wall Street

The major U.S. index futures are pointing to a sharply lower opening on Tuesday, with stocks likely to extend the pullback seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/37UwWCa
via IFTTT

Bank Of Montreal Boosts Qtly Dividend 6% - Quick Facts

Bank of Montreal (BMO, BMO.TO) announced Tuesday that its Board of Directors declared a 6 percent higher quarterly dividend of C$1.06 per share on paid-up common shares of Bank of Montreal for the first quarter of fiscal year 2020. The dividend is payable on February 26, 2020, to shareholders of record on February 3, 2020.

from RTT - Earnings https://ift.tt/34HZrkI
via IFTTT

Healthcare Stocks That Hit New Highs (XENE, AQST, DRNA...)

The following are some of the healthcare stocks that hit a new high yesterday.

from RTT - Biotech https://ift.tt/33Kmz0y
via IFTTT

AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX

Today's Daily Dose brings you news about Applied Genetic Technologies' near-term catalysts; the acquisition of Audentes by Astellas; Aldeyra's immediate catalyst; Evofem's AMPREVENCE study results and Lexicon Pharma's setback.

from RTT - Biotech https://ift.tt/2Rkrl2p
via IFTTT

KOD Dazzles, GLMD On Watch, DRIO Turns Heads.

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2OKJXXE
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Monday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2P2z3LC
via IFTTT

Mylan, Biocon Announce US Launch Of Trastuzumab Biosimilar Ogivri - Quick Facts

Pharmaceutical company Mylan N.V. (MYL) and India-based Biocon Ltd. announced Monday the U.S. launch of Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab). The product is co-developed by Mylan and Biocon.

from RTT - Biotech https://ift.tt/34HeIlI
via IFTTT

Sirona Biochem's Skin Lightening Agent Found To Be Safe At Higher Dose

Sirona Biochem Corp. (SBM.V) (SRBCF.OB) announced that its investigative skin lightening compound TFC-1067 has been successfully completed a toxicology test for an increased dose of 0.4%, in preparation for the new clinical study.

from RTT - Biotech https://ift.tt/2P24u8Q
via IFTTT

Kadmon Holdings' (KDMN) Rocking, Will The Rally Continue?

Shares of Kadmon Holdings Inc. (KDMN) have gained an impressive 53% over the last 1 month.

from RTT - Biotech https://ift.tt/35XyYQl
via IFTTT

Biotech Stocks Facing FDA Decision In December 2019

As we begin the final month of the year, it's time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

from RTT - Biotech https://ift.tt/2syJD5r
via IFTTT

Catalysts Aplenty For Can-Fite (CANF)

Can-Fite BioPharma Ltd. (CANF), a biotechnology company developing drugs that address cancer, liver and inflammatory diseases, looks forward to several milestones in 2020.

from RTT - Biotech https://ift.tt/2DpEsHk
via IFTTT

Rising Tensions In Hong Kong May Lead To Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Friday, with stocks likely to move back to the downside after trending higher in recent sessions.

from RTT - Market Analysis https://ift.tt/33tPc1J
via IFTTT

Daily Mail owner buys the i newspaper for £49.6m

DMGT will integrate some operations but appears to rule out editorial job cuts

The owner of the Daily Mail has bought the i newspaper and website for £49.6m as a new wave of media consolidation hits the UK national and regional newspaper market.

Daily Mail and General Trust (DMGT), which also owns the Mail on Sunday and Mail Online, had been the frontrunner to seal a deal after entering exclusive talks with the i’s parent, JPI Media, in September.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2Dyx38p

Inspire Medical Systems On A Roll...

Shares of Inspire Medical Systems Inc. (INSP) hit a new high in intraday trading today and are currently at $71.

from RTT - Biotech https://ift.tt/2DlhxNf
via IFTTT

Upward Momentum May Lead To Continued Strength On Wall Street

The major U.S. index futures are pointing to a modestly higher opening on Wednesday, with stocks likely to extend the upward move seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2OqchOU
via IFTTT

Did Global Cord Blood (CO) Catch Your Eye?

Shares of Global Cord Blood Corp. (CO) are down nearly 37% from their 52-week high of $7.73 recorded on March 1, 2019.

from RTT - Biotech https://ift.tt/2XQj7jD
via IFTTT

Will Third Time Prove A Charm For Baudax Bio?

Baudax Bio Inc., a spinoff from Recro Pharma Inc (REPH), began trading on the NASDAQ Capital Market under the ticker symbol "BXRX" on November 22, 2019. The shares have gained more than 50 percent over the last three trading days.

from RTT - Biotech https://ift.tt/2OMDkTs
via IFTTT

5 Top Gainers In Healthcare Sector (HEPA, ARDX, PTI...)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/33kg58l
via IFTTT

What's Driving The Rally In Dick's Sporting?

Shares of Dick's Sporting Goods Inc. (DKS) are currently up 17%, following strong third-quarter results.

from RTT - Earnings https://ift.tt/35CkXqS
via IFTTT

Ear Infections In Children Could Be Treated Now With Local Anesthesia

The U.S. Food and Drug Administration approved a new system for the delivery of ear tubes into the eardrum under local anesthesia and minimal discomfort to the patient to treat recurrent ear infections. The regulator granted approval for Tusker Medical's Tubes Under Local Anesthesia System as the first ear tube delivery system that can be performed using local anesthesia.

from RTT - Biotech https://ift.tt/2qLiOdG
via IFTTT

Futures Pointing To Flat Open But Upward Momentum May Persist

The major U.S. index futures are pointing to a roughly flat opening on Tuesday following the climb to record highs seen in the previous session.

from RTT - Market Analysis https://ift.tt/2Df7fON
via IFTTT

Analog Devices Guides Q1 Below Estimates, Declares Dividend - Quick Facts

While reporting financial results for the fourth quarter and full-year 2019 on Tuesday, Analog Devices Inc. (ADI) provided earnings and revenue guidance for the first quarter of fiscal 2020.

from RTT - Earnings https://ift.tt/2pX9Wl2
via IFTTT

Chico's FAS Backs FY19 Sales Growth Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, specialty retailer Chico's FAS Inc. (CHS) maintained its sales growth guidance for the full-year 2019 to reflect improvements in the business and tariff impact and initiated outlook for the fourth quarter.

from RTT - Earnings https://ift.tt/2OmYEQd
via IFTTT

Dollar Tree Updates Guidance, Q3 Profit Misses Estimates; Stock Plunges

Dollar Tree, Inc. (DLTR) announced the company now estimates that Section 301 tariffs will increase its cost of goods sold by approximately $19 million, or $0.06 per share, in the fourth quarter of 2019 if tariffs are fully implemented. Earnings per share for the quarter, including tariff costs, are now estimated to be in the range of $1.70 to $1.80. Consolidated net sales are projected in a range from $6.33 billion to $6.44 billion, based on a low single-digit increase in same-store sales for the enterprise.

from RTT - Earnings https://ift.tt/2KQnXIr
via IFTTT

Abercrombie & Fitch Trims FY19 Sales Growth Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Abercrombie & Fitch Co. (ANF) trimmed its sales growth guidance for the full-year 2019 and provided sales growth guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/35zZxe8
via IFTTT

Best Buy Raises FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, electronics retailer Best Buy Co., Inc. (BBY) provided outlook for the fourth quarter and raised its adjusted earnings and enterprise revenue guidance for the full-year 2020, based on the strong third-quarter profitability as well as improved expectations for the fourth quarter.

from RTT - Earnings https://ift.tt/2XVisO0
via IFTTT

Hormel Foods Guides FY20 In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter and full-year 2019 on Tuesday, branded food company Hormel Foods Corp. (HRL) initiated earnings and net sales guidance for the full-year 2020, which is in line with analysts' estimates.

from RTT - Earnings https://ift.tt/33hF0JT
via IFTTT

Dycom Industries Guides Q4 Below Estimates - Quick Facts

While reporting financial results for the third quarter of fiscal 2020 on Tuesday, Dycom Industries, Inc. (DY) also provided earnings and revenue guidance for the fourth quarter ending January 25, 2020.

from RTT - Earnings https://ift.tt/2QRCKWZ
via IFTTT

Did Emergent BioSolutions (EBS) Catch Your Eye?

Shares of Emergent BioSolutions Inc (EBS) are down 26% from their 52-week high of $73.89 recorded on December 3, 2018, and stock may be worth a look now.

from RTT - Biotech https://ift.tt/2pWiRTO
via IFTTT

CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP

Today's Daily Dose brings you news about the FDA rejecting Adamis Pharma's ZIMHI high-dose naloxone injection, proposed for the reversal of opioid overdose; ChemoCentryx' ANCA-associated vasculitis trial results; CymaBay pulling the plug on Seladelpar trials; Global Blood Therapeutics's scoring FDA nod for sickle cell disease drug, and Zogenix upcoming catalyst in March, among others.

from RTT - Biotech https://ift.tt/35FVT2x
via IFTTT

Today's Top 5 Gainers In Healthcare Sector (SRNE, MDCO, RAPT...)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2pUsYsc
via IFTTT

Did Zoetis Catch Your Eye?

Zoetis is an animal health company - catering to the health of cattle, pigs, poultry, sheep, fish, dogs, cats and horses. The Company has roughly 300 product lines, which are sold in more than 100 countries.

from RTT - Biotech https://ift.tt/2siElLv
via IFTTT

Trade Deal Optimism, M&A News May Generate Early Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday following the modest pullback seen last week.

from RTT - Market Analysis https://ift.tt/2QZDl9p
via IFTTT

MYOV Up Over 130% In 5 Days, What's Next?

Shares of Myovant Sciences Ltd. (MYOV) have gained more than 130% over the last 5 trading days, thanks to HERO, the Company's phase III study of once-daily, oral Relugolix in men with advanced prostate cancer.

from RTT - Biotech https://ift.tt/37z1zgl
via IFTTT

AQST Soars On FDA Approval

Shares of Aquestive Therapeutics, Inc. (AQST) are up 21.15% in pre-market trading on Monday, following FDA approval of its drug Exservan for the treatment of neurological disorder amyotrophic lateral sclerosis (ALS).

from RTT - Biotech https://ift.tt/35pnVz4
via IFTTT

Healthcare Stocks That Hit New Highs (MTEM, AMGN, AMED...)

The following are some of the healthcare stocks that hit a new high on Friday, November 22, 2019.

from RTT - Biotech https://ift.tt/2rmEJrP
via IFTTT

Avadel On A High - Eventful Days Ahead

Shares of Avadel Pharmaceuticals plc (AVDL) are up an impressive 129 percent year-to-date.

from RTT - Biotech https://ift.tt/2KNJ4uH
via IFTTT

Have You Selected SEM For Your Portfolio?

Shares of Select Medical Holdings Corp. (SEM), which have been hitting new highs, have gained 5 percent over the last 5 trading days.

from RTT - Biotech https://ift.tt/2KO6Zu2
via IFTTT

Traders May Look To Pick Up Stocks At Somewhat Reduced Levels

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to regain some ground after moving mostly lower over the past few sessions.

from RTT - Market Analysis https://ift.tt/2QL4k8j
via IFTTT

J.M. Smucker Lowers FY20 Outlook - Quick Facts

While reporting its financial results for the second quarter on Friday, J. M. Smucker Co. (SJM) lowered its outlook for fiscal 2020 adjusted earnings, net sales growth and comparable sales growth.

from RTT - Earnings https://ift.tt/2QI21mE
via IFTTT

Foot Locker Q3 Profit Tops Estimates, Comps. Up 5.7%; Shares Jump

Foot Locker, Inc. (FL) reported third-quarter non-GAAP earnings of $1.13 per share compared to $0.95, a year ago. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $1.08, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2KJOQh6
via IFTTT

Healthcare Stocks That Hit New Highs (KMDA, MGLN)

The following are the healthcare stocks that hit a new 52-week high on Thursday

from RTT - Biotech https://ift.tt/2reOGre
via IFTTT

FDA Approves AZN's Calquence, GLYC's Data To Be Delayed, ENLV Withdraws Offering

Today's Daily Dose brings you news about FDA approval of AstraZeneca's CALQUENCE; delay in the release of GlycoMimetics' phase III trial of Uproleselan in AML and Onconova's agreement with Knight Therapeutics.

from RTT - Biotech https://ift.tt/34bUoIK
via IFTTT

Did This Stock Catch Your Eye? (BHVN)

Stock on the move...

from RTT - Biotech https://ift.tt/2pEu9f8
via IFTTT

Buying Interest May Re-emerge After Yesterday's Weakness

The major U.S. index futures are pointing to a slightly higher opening on Thursday, with stocks likely to see initial strength after coming under pressure over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2KCoihN
via IFTTT

Americold To Acquire Nova Cold For C$337 Mln - Quick Facts

Americold Realty Trust (COLD) announced Thursday it agreed to acquire Canada-based Nova Cold Logistics for C$337 million from Brookfield Business Partners L.P. (BBU), together with its institutional partners. The closing of the acquisition is subject to customary closing conditions and is expected to occur in the first quarter of 2020.

from RTT - Earnings https://ift.tt/2QBvcYe
via IFTTT

BJ's Wholesale Adjusts FY19 Outlook; Authorizes $250 Mln Share Buyback

While reporting financial results for the third quarter on Thursday, BJ's Wholesale Club Holdings Inc. (BJ) adjusted its earnings and net sales guidance for the full-year 2019. For the third quarter, comparable club sales excluding gasoline sales increased 1.1 percent.

from RTT - Earnings https://ift.tt/335IsHh
via IFTTT

Stage Stores Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, retailer Stage Stores Inc. (SSI) raised its guidance for the full-year 2019, based on the outstanding results in the third quarter and strong momentum entering the fourth quarter. For the third quarter, the company also reported comparable sales growth of 17.4 percent.

from RTT - Earnings https://ift.tt/2r9LcGu
via IFTTT

Amgen Boosts FY19 Outlook After Otezla Acquisition - Quick Facts

Amgen (AMGN) on Thursday raised its adjusted earnings and revenue guidance for the full-year 2019 following the completion of the Otezla acquisition on Wednesday. Otezla, along with certain related assets and liabilities, was acquired for $13.4 billion in cash, or about $11.2 billion, net of the present value of $2.2 billion in anticipated future cash tax benefits.

from RTT - Earnings https://ift.tt/2s5aE0e
via IFTTT

Did These Stocks Catch Your Eye? (CTLT, VAR)

The stocks on the move.

from RTT - Biotech https://ift.tt/35w0EM3
via IFTTT

Futures Pointing To Initial Weakness Amid Renewed Trade Worries

The major U.S. index futures are pointing to a lower opening on Wednesday following the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2KG0F85
via IFTTT

Target Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, retailer Target Corp. (TGT) initiated adjusted earnings and comparable sales guidance for the fourth quarter as well as raised adjusted earnings guidance for the full-year 2019.

from RTT - Earnings https://ift.tt/2pEgTHu
via IFTTT

Lowe's Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, home improvement retailer Lowe's Cos., Inc. (LOW) raised its adjusted earnings guidance for the full-year 2019, while maintaining annual sales and comparable sales growth guidance.

from RTT - Earnings https://ift.tt/2D2X1AI
via IFTTT

Biosimilar Race: U.S. Lags Behind Europe

It's been more than 4 years since the first biosimilar Zarxio was approved in the U.S. Zarxio, developed by Sandoz, a Novartis division, is a biosimilar version of Amgen Inc.'s (AMGN) Neupogen, and it received the regulatory nod in the U.S. in March 2015.

from RTT - Biotech https://ift.tt/37lPpHr
via IFTTT

Healthcare Stocks That Hit New Highs (SEM, GMED, TMO...)

Healthcare Stocks That Hit New Highs (SEM, GMED, TMO...)

from RTT - Biotech https://ift.tt/344R4iO
via IFTTT

Did These Stocks Catch Your Eye? (ZYME, NVTA)

The stocks on the move...

from RTT - Biotech https://ift.tt/2s0rNbo
via IFTTT

TJX Companies Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, off-price retailer TJX Companies, Inc. (TJX) raised earnings guidance for the full-year 2020 and provided fourth-quarter outlook. For the third quarter, the company reported that consolidated comparable store sales rose 4 percent, compared to an increase of 7 percent in the same period last year.

from RTT - Earnings https://ift.tt/2OvUNiC
via IFTTT

Markets May Continue To Benefit From Recent Upward Momentum

The major U.S. index futures are pointing to a higher opening on Tuesday, with stocks likely to see further upside after moving modestly higher over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2QtLp1P
via IFTTT

Healthcare Stocks That Hit New Highs (XBIT, DRNA, CRSP...)

The following are the healthcare stocks that hit a new 52-week high on Monday.

from RTT - Biotech https://ift.tt/2KQ9NXV
via IFTTT

TransDigm Group Issues FY20 Outlook Below View- Quick Facts

While reporting its fourth-quarter financial results on Tuesday, TransDigm Group Inc. (TDG) forecast fiscal 2020 adjusted earnings in a range of $19.80 to $21.20 per share, compared with $18.27 per share in fiscal 2019.

from RTT - Earnings https://ift.tt/2pAZe3q
via IFTTT

Kohl's Slashes FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the third quarter on Tuesday, retailer Kohl's Corp. (KSS) slashed its adjusted earnings guidance for the full-year 2019. For the third quarter, the company reported that comparable sales increased 0.4 percent.

from RTT - Earnings https://ift.tt/2OuqbON
via IFTTT

Medtronic Boosts FY20 Adj. Earnings Outlook - Quick Facts

While reporting financial results for the second quarter on Tuesday, Medtronic plc. (MDT) raised its adjusted earnings guidance for the full-year 2020, while maintaining organic revenue growth outlook.

from RTT - Earnings https://ift.tt/2XsGvDt
via IFTTT

MAXIMUS Guides FY20 In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter and full-year 2019 on Tuesday, MAXIMUS, Inc. (MMS) initiated earnings and revenue guidance for the full year 2020.

from RTT - Earnings https://ift.tt/2Qx9pkx
via IFTTT

Home Depot Cuts 2019 Sales Guidance; Shares Plunge - Quick Facts

The Home Depot (HD) announced, for fiscal 2019, the company now expects sales to grow by approximately 1.8 percent and comp sales for the comparable 52-week period to increase approximately 3.5 percent. Previously, the company projected sales growth of 2.3 percent and comp sales growth of 4.0 percent. The Home Depot reaffirmed fiscal year earnings per share guidance and expects earnings per share growth of approximately 3.1 percent from fiscal 2018 to $10.03.

from RTT - Earnings https://ift.tt/2Xr9dEM
via IFTTT

JinkoSolar Q3 Profit Surges - Quick Facts

Solar module manufacturer JinkoSolar Holding Co., Ltd. (JKS) reported Tuesday that net income attributable to the company's ordinary shareholders was RMB363.6 million or $50.9 million in the third quarter, sharply higher than RMB189.1 million in the year-ago quarter. Earnings per American depositary share (ADS) were RMB4.664 or $0.652, compared to RMB4.840 last year.

from RTT - Earnings https://ift.tt/37kTr2Q
via IFTTT

KRTX Makes Giant Leap, The Medicines' Working Well, AGRX On The Move

Today's Daily Dose brings you news about Karuna Therapeutics' psychosis trial results, The Medicines Co's detailed results from ORION-9 study, Dicerna's collaboration with Novo Nordisk and the 25th biosimilar approved by the FDA.

from RTT - Biotech https://ift.tt/32Z9WOH
via IFTTT

Watch Out For Tuesday - Will Myovant's HERO Prove Its Mettle?

Myovant Sciences Ltd. (MYOV) is slated to present results from its phase III study of once-daily, oral Relugolix in men with advanced prostate cancer on Tuesday, November 19, 2019.

from RTT - Biotech https://ift.tt/2r1jYll
via IFTTT

Report Of Pessimism About Trade Deal May Weigh On Wall Street

The major U.S. index futures have erased an earlier advance and are currently pointing to a roughly flat opening on Monday following last week's climb to record highs.

from RTT - Market Analysis https://ift.tt/2XqPcOP
via IFTTT

First Contact Lens To Slow Progression Of Myopia Approved

The U.S. Food and Drug Administration approved the first contact lens developed for slowing the progression of myopia or nearsightedness in children between the ages 8 and 12 years at the initiation of treatment. This could also help in ultimately reducing risk of developing other eye problems. The regulator granted approval for CooperVision Inc.'s MiSight contact lens.

from RTT - Biotech https://ift.tt/3302R0i
via IFTTT

FDA Approves Pfizer's ABRILADA, Fifth Biosimilar To Humira

Pfizer Inc.'s ( PFE) ABRILADA, a biosimilar to Humira, has received FDA approval for the treatment of certain patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis.

from RTT - Biotech https://ift.tt/2CSsZ2P
via IFTTT

A Big Day Awaits Karnua Therapeutics

Karuna Therapeutics (KRTX) is all set for the big day as the Company is scheduled to report results from its phase II clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia on Monday.

from RTT - Biotech https://ift.tt/2Xmgshr
via IFTTT

Healthcare IPO For The Week Ahead

The IPO activity in the U.S. healthcare sector has had a strong showing, with 12 listings in October and has been somewhat tepid with around 5 listings in the first half of November.

from RTT - Biotech https://ift.tt/2KsaZjH
via IFTTT

Renewed Optimism About Trade Deal May Generate Early Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session nearly flat.

from RTT - Market Analysis https://ift.tt/37ahKAs
via IFTTT

J. C. Penney Q3 Loss Narrows, Reaffirms FY19 Comp Sales Outlook - Quick Facts

J. C. Penney Co., Inc. (JCP) reported Friday a third-quarter net loss of $93 million, or $0.29 per share, narrower than a net loss of $151 million, or $0.48 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/32QQNP5
via IFTTT

Keep An Eye On DGII, RDNT, PGNY.

What's moving these stocks?

from RTT - Earnings https://ift.tt/2Xj6X2E
via IFTTT

Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)

The following are the healthcare stocks that hit a new 52-week high on Thursday.

from RTT - Biotech https://ift.tt/2rF6mMG
via IFTTT

Today's Top 5 Gainers In Healthcare Sector (CLSN, HROW, AXNX...)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/37amztx
via IFTTT

Futures Pointing To Initial Weakness On Wall Street

The major U.S. index futures are pointing to a lower opening on Thursday following the lackluster performance seen over the past several sessions.

from RTT - Market Analysis https://ift.tt/2NKVcie
via IFTTT

IGT Backs FY019 Adjusted EBITDA Outlook; Declared Divided - Quick Facts

While reporting financial results for the third quarter on Thursday, International Game Technology plc (IGT) maintained its full-year 2019 guidance for adjusted EBITDA, while cutting annual capital expenditures outlook. The company also declared a quarterly cash dividend.

from RTT - Earnings https://ift.tt/2KmowJJ
via IFTTT

Weibo Corp. Q3 Adj. EPS Top Estimates - Quick Facts

Chinese social media company Weibo Corp. (WB) announced Thursday that net income attributable to SINA for the third quarter was $146.2 million or $0.64 per share, higher than $165.3 million or $0.73 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2rJDZgv
via IFTTT

Merck KGaA Q3 Profit Edges Up, Raises FY19 View; Stock Dips

German science and technology company Merck KGaA reported Thursday a slight increase in third-quarter profit, despite good growth in sales. The company further lifted its fiscal 2019 earnings and sales view following the closing of the Versum Materials acquisition. Shares of Merck were losing around 2 percent in the morning trading in Germany.

from RTT - Earnings https://ift.tt/2Qfh4Um
via IFTTT

Safestore Holdings FY Group Revenue Up 5.5% - Quick Facts

Safestore Holdings plc. (SAFE.L) reported Thursday that Group revenue for the full year increased 5.5 percent to 151.8 million pounds from 143.9 million pounds in the prior year. Group revenue for the year increased 5.6 percent at CER.

from RTT - Earnings https://ift.tt/2NMoKvH
via IFTTT

Great Portland Estates H1 Pre-tax Profit Rises - Quick Facts

Great Portland Estates plc. (GPOR.L) reported that its profit before tax for the six months ended 30 September 2019 rose to 44.4 million pounds from 40.4 million pounds in the same period last year.

from RTT - Earnings https://ift.tt/32Hb35r
via IFTTT

This Day That Year: Vapotherm

Shares of Vapotherm Inc. (VAPO) are down nearly 61 percent from a high of $24.63 recorded on July 2, 2019, and trade around $9.

from RTT - Biotech https://ift.tt/2KiugUY
via IFTTT

Genus 4-month Adj. Pre-tax Profit Rises; Expects To Meet FY Growth Outlook

Genus plc (GNS.L), an animal genetics company, said Thursday that for the four months to 31 October 2019, adjusted profit before tax for the Group showed good growth from the prior year.

from RTT - Earnings https://ift.tt/2CKcCFa
via IFTTT

Burberry Group H1 Pretax Profit Rises; Confirms FY Outlook - Quick Facts

Burberry Group plc (BRBY.L) on Thursday reported profit before tax of 193 million pounds for the 26 weeks ended 28 September 2019, up 11 percent from 174 million pounds in the same period last year. Earnings per share increased to 36.4 pence from 31.6 pence a year ago.

from RTT - Earnings https://ift.tt/352XyhY
via IFTTT

Healthcare Stocks That Hit New Highs (ARWR, ELMD, SGEN...)

The following are the healthcare stocks that hit a new 52-week high on Wednesday.

from RTT - Biotech https://ift.tt/32MF18n
via IFTTT

National Grid 6-month Pre-tax Profit Down 23% - Quick Facts

National Grid PLC (NG.L, NGG) on Thursday reported profit before tax of 404 million pounds for the six months ended 30 September 2019, down 23 percent from 522 million pounds in the same period last year.

from RTT - Earnings https://ift.tt/2XbYmyu
via IFTTT

Henkel Q3 Profit Down 9.4%; Confirms FY19 Outlook - Quick Facts

German consumer goods maker Henkel AG & Co. KGaA (HENOY, HENKY) Thursday reported that its third-quarter net income attributable to shareholders declined 9.4 percent to 556 million euros from 614 million euros in the year-ago period. Earnings per preferred share decreased to 1.28 euros from 1.42 euros in the prior-year period.

from RTT - Earnings https://ift.tt/354Gfgv
via IFTTT

K+S Group Q3 EBITDA More Than Doubles; Revises FY19 Outlook - Quick Facts

K+S Group (SDFG) reported Thursday that its third-quarter EBITDA more than doubled to 80.6 million euros from 36.4 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2qb3Kpz
via IFTTT

Caladrius Biosciences: Matters Of The Heart...

Shares of Caladrius Biosciences Inc. (CLBS) are down 25 percent year-to-date while the iShares Nasdaq Biotechnology ETF (IBB), a bellwether of investor sentiment, is up nearly 15 percent for the same period.

from RTT - Biotech https://ift.tt/35a4ASv
via IFTTT

Today's Top 5 Gainers In Healthcare Sector (IDYA, ELMD, CLBS.)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2ObCzml
via IFTTT

Renewed Uncertainty About Trade Deal May Weigh On Wall Street

The major U.S. index futures are pointing to a lower opening on Wednesday following the lackluster performance seen over the past few sessions.

from RTT - Market Analysis https://ift.tt/2Kh1mEH
via IFTTT

Energizer Holdings Guides FY20 Below Estimates - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, battery manufacturer Energizer Holdings, Inc. (ENR) initiated adjusted earnings and revenue growth guidance for the full year 2020, which was below analysts' estimates.

from RTT - Earnings https://ift.tt/2KgGvBp
via IFTTT

Loblaw Expects To Deliver Positive Adj. EPS Growth For FY19 - Quick Facts

Loblaw expects to deliver positive Adj. EPS growth for FY19 - Quick Facts

from RTT - Earnings https://ift.tt/33VGQks
via IFTTT

China Yuchai International Q3 Profit More Than Halves - Quick Facts

China Yuchai International Ltd. (CYD) reported that total net profit attributable to China shareholders for the fourth quarter was RMB 50.33 million ($7.12 million), or earnings per share of RMB 1.23 ($0.17), compared to RMB 128.52 million, or RMB 3.15 per share in the same quarter in 2018.

from RTT - Earnings https://ift.tt/2QcSMub
via IFTTT

SSE Posts Pre-tax Profit In H1; Raises FY Adj. EPS Outlook - Quick Facts

Electric utility SSE plc (SSE.L) reported Wednesday that its first-half pre-tax profit was 128.9 million pounds, compared to loss of 284.6 million pounds last year. Earnings per share from continuing operations were 6.2 pence, compared to loss of 26.4 pence a year ago.

from RTT - Earnings https://ift.tt/2XaINHf
via IFTTT

J D Wetherspoon Q1 LFL Sales Up 5.3% - Quick Facts

J D Wetherspoon plc (JDW.L) reported Wednesday that for the 13 weeks to 27 October 2019, like-for-like sales increased by 5.3 percent and total sales by 5.6 percent.

from RTT - Earnings https://ift.tt/351dyRB
via IFTTT

Medigene 9-month Net Loss Widens; Confirms FY19 Outlook - Quick Facts

Medigene AG (MDGEF.PK) on Wednesday reported net loss for the first nine months of 2019 of 20.00 million euros, wider than net loss of 13.16 million euros in the year-ago period. Loss per share widened to 0.81 euros from 0.56 euros in the same period last year.

from RTT - Earnings https://ift.tt/2O8jXDR
via IFTTT

Bechtle Q3 Profit Rises; Confirms FY19 Outlook - Quick Facts

Information technology company Bechtle AG (BC8G) reported Wednesday that its third-quarter earnings after taxes grew 23.8 percent to 40.22 million euros from 32.49 million euros last year. Earnings per shares were 0.96 euro, up from 0.77 euro last year.

from RTT - Earnings https://ift.tt/2pdadjg
via IFTTT

Leoni Slips To Loss In Q3; Reiterates FY19 Outlook - Quick Facts

Leoni AG (LEOGN) on Wednesday reported third-quarter consolidated net loss of 88 million euros, compared to net income of 23 million euros in the previous-year quarter. Loss per share for the quarter was 2.69 euros, compared to earnings per share of 0.71 euros a year ago.

from RTT - Earnings https://ift.tt/2pZakQ2
via IFTTT

Top 5 Losers In Healthcare Sector (SLDB, DPLO, TTOO...)

The following are some of the healthcare stocks that posted the biggest percentage decline on Tuesday.

from RTT - Biotech https://ift.tt/2X8fjdf
via IFTTT

Today's Top 5 Gainers In Healthcare Sector (AMRN, DMAC, TNXP...)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/36ZOcW6
via IFTTT

Trump Speech In Focus On Wall Street

The major U.S. index futures are pointing to a roughly flat opening on Tuesday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2Kgz0Kz
via IFTTT

Advanced Energy Industries Guides Q4 Adj. EPS In Line - Quick Facts

While reporting financial results for the third quarter on Tuesday, Advanced Energy Industries, Inc. (AEIS) provided earnings and revenue guidance for the fourth quarter.

from RTT - Earnings https://ift.tt/2O7OnpE
via IFTTT

Nissan Motor H1 Profit Down 73.5%; Cuts FY Outlook - Quick Facts

Japanese carmaker Nissan Motor Co. Ltd. (NSANF.PK, NSANY.PK) reported Tuesday that its that net income attributable to owners of the parent for the six-month period to September 30, 2019 fell 73.5 percent to 65.4 billion yen from 246.3 billion yen in the prior year.

from RTT - Earnings https://ift.tt/2panLfo
via IFTTT

Rockwell Automation Guides FY20 Above Estimates - Quick Facts

While reporting financial results for the fourth quarter and full-year 2019 on Tuesday, Rockwell Automation, Inc. (ROK) initiated earnings and sales growth guidance for the full-year 2020, which is well above analysts' estimates.

from RTT - Earnings https://ift.tt/2Kg6M2B
via IFTTT

JetBlue Airways October Traffic, Capacity Rise; Load Factor Declines

JetBlue Airways Corp. (JBLU) reported Tuesday its preliminary traffic results for October 2019. Traffic in October increased 6.2 percent from the year-ago period, on a capacity increase of 6.7 percent.

from RTT - Earnings https://ift.tt/2ruKX8S
via IFTTT

Advance Auto Parts Reaffirms FY19 Sales Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Advance Auto Parts Inc. (AAP) reaffirmed its net sales guidance for the full-year 2019, while trimming comparable store sales guidance.

from RTT - Earnings https://ift.tt/2NEydW1
via IFTTT

Linde Q3 Profit Rises; Lifts FY Adj. Pro Forma Earnings Outlook - Quick Facts

Linde plc (LIN) reported Tuesday that its third-quarter net income rose to $735 million from $461 million in the prior-year quarter. However, earnings per share declined to $1.35 from $1.58 last year on higher number of shares outstanding.

from RTT - Earnings https://ift.tt/2NH9uAl
via IFTTT

Deutsche Post DHL Q3 Profit Rises, Backs EBIT View For Years Ahead; Stock Up

Shares of Deutsche Post DHL Group were gaining around 5 percent in the morning trading in Germany after the package delivery and supply chain management company reported Tuesday significantly higher profit in its third quarter. Looking ahead, the company anticipates a traditionally strong holiday season in the fourth quarter. The company also confirmed its annual earnings outlook.

from RTT - Earnings https://ift.tt/2NI8fB7
via IFTTT

Daqo New Energy Raises FY19 Production Outlook - Quick Facts

While reporting financial results for the third quarter, Daqo New Energy Corp. (DQ), a manufacturer of high-purity polysilicon for the global solar PV industry, on Tuesday announced polysilicon production and sales guidance for the fourth quarter and raised full-year 2019 polysilicon production guidance.

from RTT - Earnings https://ift.tt/2X4KRR4
via IFTTT

Healthcare Stocks That Hit New Highs (DXCM, ZLAB, PODD)

The following are the healthcare stocks that hit a new 52-week high on Monday.

from RTT - Biotech https://ift.tt/32y3iik
via IFTTT

Keep An Eye On BREW, ICUI, GO.

What's moving these stocks?

from RTT - Earnings https://ift.tt/2Q5EkUZ
via IFTTT

Anglo American Updates 2019-2021 Production Outlook For Bulks Businesses

Anglo American plc (AAUKY.PK, AAL.L) said Tuesday it is hosting an analyst and investor visit to Queensland, Australia this week to provide a detailed update on the company's Bulks businesses.

from RTT - Earnings https://ift.tt/2X7bmVW
via IFTTT

AVEVA Posts Pre-tax Profit In H1; Says Outlook Remains Positive - Quick Facts

AVEVA Group Plc (AVV.L) reported Tuesday that its profit before tax for the first half of fiscal 2020 was 24.0 million pounds, compared to loss before tax of 5.5 million pounds a year ago. Earnings per share were 11.13 pence, compared to loss per share of 3.61 pence a year ago.

from RTT - Earnings https://ift.tt/2rtkIzE
via IFTTT

Land Securities Group Slips To Loss In H1 - Quick Facts

Real estate investment trust Land Securities Group Plc. (LAND.L) reported that its loss before tax for the six-month period ended 30 September 2019 was 147 million pounds, compared to profit before tax of 42 million pounds in the same period in the prior year. The loss reflects a greater fall in the value of the company's assets in the latest period.

from RTT - Earnings https://ift.tt/2X4mlQ6
via IFTTT

ITV 9-month Total Revenue Down 1%; Says On Track To Deliver FY View

ITV Plc (ITV.L) said Tuesday that total revenue for the nine months ended 30 September 2019 declined 1 percent from the year-ago period and said it is on track to deliver its full-year guidance.

from RTT - Earnings https://ift.tt/2K9JA5V
via IFTTT

Novartis: Phase III PREVENT Trial Met Primary Endpoint Of ASAS40 At Week 16

Swiss drug major Novartis AG (NVS) announced detailed results from the Phase III PREVENT trial that evaluates the efficacy and safety of Cosentyx, or secukinumab, in patients with non-radiographic axial spondyloarthritis or nr-axSpA.

from RTT - Biotech https://ift.tt/2O2cTsj
via IFTTT

1&1 Drillisch 9-month EBIT Down 4.3% - Quick Facts

1&1 Drillisch AG (DRHKF.PK, UDIRF.PK), a German telecommunication service provider, reported Tuesday that its consolidated EBIT or earnings before interest and taxes for the first nine months of 2019 declined 4.3 percent to 391.3 million euros from 409.1 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2Kerm3l
via IFTTT

Today's Top 5 Gainers In Healthcare Sector (CABA, INMD, AQST.)

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2qMHEte
via IFTTT

A buyer for British Steel is welcome but what’s Jingye’s strategy? | Nils Pratley

It’s hard to see why the Chinese firm wants to take over a loss-making business in a tough market

Half the woes for steelmakers in Britain derive from dumping into world markets by Chinese producers, or so we have been told for a couple of decades. So it is a strange sort of rescue for British Steel that ownership should pass to a little-known Chinese conglomerate, Jingye, offering a vague promise to invest a large sum.

Any buyer is better than none, of course, since the effects of irreversible closure of the Scunthorpe steelworks would be appalling. Top of the list would be 4,000 jobs, with another 20,000 in the supply chain. Then there would be the huge environmental clean-up costs.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/33BNdJD

Profit Taking May Lead To Initial Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Monday, with stocks likely to give back ground after inching up to record closing highs last Friday.

from RTT - Market Analysis https://ift.tt/2X3gLgQ
via IFTTT

FDA Rejects Lipocine's TLANDO Yet Again

The FDA has turned down Lipocine Inc.'s (LPCN) TLANDO, an oral testosterone product candidate for testosterone replacement therapy in adult males for hypogonadism, yet again.

from RTT - Biotech https://ift.tt/2qFnBx6
via IFTTT

What Awaits ASMB, DRRX, EIGR At The Liver Meeting?

The announcement of clinical trial results is a major market-moving event for pharma/biotech stocks. Listed below are some of the pharma/biotech stocks to watch out for today and tomorrow.

from RTT - Biotech https://ift.tt/2NAc4If
via IFTTT

Keep An Eye On ATNX, OCUL, SGMS.

What's moving these stocks?

from RTT - Earnings https://ift.tt/36VSBcD
via IFTTT

LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155

Today's Daily Dose brings you news about Alnylam's new positive efficacy results from its ongoing phase II open-label extension (OLE) study of Lumasiran for the treatment of primary hyperoxaluria type; Five Prime's initial safety data from its phase I clinical trial of FPT155 in patients with advanced solid tumors and Lipocine's much-awaited catalyst.

from RTT - Biotech https://ift.tt/34ISWxs
via IFTTT

Futures Pointing To Roughly Flat Open On Wall Street

The major U.S. index futures are currently pointing to a roughly flat opening on Friday, as traders seem likely to retreat to the sidelines once again.

from RTT - Market Analysis https://ift.tt/32wptoW
via IFTTT

Ameren Narrows FY19 EPS Outlook Range - Quick Facts

While reporting financial results for the third quarter on Friday, electric and gas utility Ameren Corp. (AEE) narrowed its earnings guidance for the full-year 2019, while increasing the mid-point by three cents per share.

from RTT - Earnings https://ift.tt/32qj7rm
via IFTTT

Duke Energy Narrows FY19 EPS Outlook Range - Quick Facts

While reporting financial results for the third quarter on Friday, Duke Energy Corp. (DUK) narrowed its earnings guidance range for the full year 2019 to raise the midpoint into the upper half of our original range, based upon the results through the third quarter.

from RTT - Earnings https://ift.tt/34Ddvv6
via IFTTT

Enerplus Tightens FY19 Production Guidance Range - Quick Facts

While reporting financial results for the third quarter on Friday, Enerplus Corp. (ERF, ERF.TO) tightened its production guidance range for the full-year 2019.

from RTT - Earnings https://ift.tt/34K5wfM
via IFTTT

Magna International Cuts FY19 Outlook; Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Friday, automotive supplier Magna International Inc. (MG.TO, MGA) lowered its net income and sales outlook for the full-year 2019, largely to reflect estimated lost volume related to the GM strike and higher launch costs.

from RTT - Earnings https://ift.tt/2X4LYAx
via IFTTT

National Vision Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, optical retail company National Vision Holdings, Inc. (EYE) raised its adjusted net income, net revenue and adjusted comparable store sales growth for the full-year 2019.

from RTT - Earnings https://ift.tt/2qALLsj
via IFTTT

Wolverine World Wide Lowers FY19 Earnings Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Wolverine World Wide, Inc. (WWW) lowered its earnings and adjusted earnings guidance for the full year 2019 to reflect estimated new tariff costs in the fourth quarter, while maintaining annual revenue outlook.

from RTT - Earnings https://ift.tt/34F7sqc
via IFTTT

AmerisourceBergen Issues FY20 Outlook - Quick Facts

While reporting its financial results for the fourth quarter on Thursday, AmerisourceBergen Corp. (ABC) issued its financial outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/32pQVF5
via IFTTT

Dentsply Sirona Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Thursday, Dentsply Sirona, Inc. (XRAY) raised its adjusted earnings guidance for the full-year 2019, while maintaining annual revenue outlook.

from RTT - Earnings https://ift.tt/2NPeaTx
via IFTTT

Healthcare Stocks That Hit New Highs (XOMA, MNTA, XGN...)

The following are the healthcare stocks that hit a new 52-week high on Wednesday.

from RTT - Biotech https://ift.tt/2qz3hx2
via IFTTT

Air Products Guides FY20 Adj. EPS In Line - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2019 on Thursday, Air Products and Chemicals, Inc. (APD) established adjusted earnings guidance for the full year 2020 and the first quarter of fiscal 2020.

from RTT - Earnings https://ift.tt/34BcFPE
via IFTTT

Canadian Natural Q3 Profit Down, Issues FY19 Production Guidance - Quick Facts

Canadian Natural Resources Ltd. (CNQ, CNQ.TO) reported Thursday that its third-quarter net earnings plunged to C$1.03 billion or C$0.87 per share from last year's C$1.80 billion or C$1.47 per share.

from RTT - Earnings https://ift.tt/32odycV
via IFTTT

Renewi Posts Pre-tax Loss In H1; Reiterates FY Outlook - Quick Facts

Waste-to-product company Renewi Plc (RWI.L) reported Thursday that its loss before tax from continuing operations for the six months ended 30 September 2019 was 17.8 million euros, compared to profit before tax of 21.8 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2PYg9aP
via IFTTT

Inchcape Q3 Group Revenue Up 5%; To Acquire Autolider For GBP 47 Mln

Inchcape Plc (INCH.L), a multi-brand automotive distributor and retailer, Thursday reported that its third-quarter group revenue was 2.4 billion pounds, up 5 percent year-on-year in actual currency and up 3 percent at constant currency.

from RTT - Earnings https://ift.tt/2WSp3Ir
via IFTTT

Derwent London Says Year To Date Total Lettings Total GBP 33.5 Mln

Derwent London PLC (DLN.L) reported that its total lettings year to date totaled 33.5 million pounds, on 486,600 sq ft. These were on average 7.0 percent above December 2018 ERV.

from RTT - Earnings https://ift.tt/2Nqr8bx
via IFTTT

IMI Expects FY19 Results To Be In-line With Market Expectations

IMI plc (IMI.L), a specialist engineering company, said Thursday that based on current market conditions, it expects full-year 2019 results to be in-line with current market expectations.

from RTT - Earnings https://ift.tt/32r8qEG
via IFTTT

Hikma Pharmaceuticals Reiterates Group FY Outlook - Quick Facts

Hikma Pharmaceuticals PLC (HIK.L, HKMPY) on Thursday reiterated its full year guidance for the Group in 2019.

from RTT - Earnings https://ift.tt/36FWxOL
via IFTTT

Persimmon Says Trading Over Summer In Line With Expectations - Quick Facts

UK-based home builder Persimmon Plc. (PSN.L) said Thursday that trading over the summer weeks was in line with its expectations, with the Group seeing the usual pick-up in customer activity while moving into the autumn season.

from RTT - Earnings https://ift.tt/32uhHw5
via IFTTT

Rolls Royce Sees FY Operating Profit, FCF Towards Low End Of Outlook Range

Rolls Royce Holdings plc (RYCEF.PK, RR.L, RYCEY.PK) said Thursday that despite improved trading since the first half of the year, it now expects full year operating profit and free cash flow or FCF outcome towards the lower end of its guidance ranges.

from RTT - Earnings https://ift.tt/2pFePPC
via IFTTT

Lagardere Q3 Revenue Up 5.5%; Confirms FY19 Recurring EBIT Growth Outlook

French conglomerate Lagardere SCA (LGDDF.PK) on Thursday reported a 5.5 percent increase in revenue for the third quarter to 2.00 billion euros from 1.90 billion euros in the year-ago period. On a like-for-like basis, sales for the quarter increased 4.1 percent.

from RTT - Earnings https://ift.tt/2WQnPxj
via IFTTT

Keep An Eye On IFRX, VNDA, DXCM.

What's moving these stocks?

from RTT - Earnings https://ift.tt/2JXeCxY
via IFTTT

Kirin Holdings 9-month Profit Down 79.6%; Affirms FY Outlook - Quick Facts

Kirin Holdings Co. Ltd. (KNBWF.PK, KNBWY.PK), a Japanese manufacturer of alcohol beverages and soft drinks, reported Thursday that its profit attributable to owners of the company for the nine months ended September 30, 2019 fell 79.6 percent to 26.3 billion yen from 128.9 billion yen in the previous-year period. Earnings per share plunged to 29.83 yen from 143.22 yen last year.

from RTT - Earnings https://ift.tt/2NPZ3t0
via IFTTT

Rheinmetall 9-month Operating Earnings Rise; Lowers FY19 Revenue Growth Outlook

German defense contractor Rheinmetall AG (RNMBF.PK) reported Thursday that its operating earnings for the first nine months of 2019 rose 3.9 percent to 262 million euros from 252 million euros in the previous-year period. Earnings per share increased 5 percent to 3.77 euros from 3.59 euros last year.

from RTT - Earnings https://ift.tt/2NLKarS
via IFTTT

UniCredit Q3 Profit Surges; Affirms FY19 Outlook - Quick Facts

Italian lender UniCredit SpA (UCG, UNCFF.PK) on Thursday said its net profit attributable to the Group for the third quarter surged to 1.10 billion euros from 29 million euros last year.

from RTT - Earnings https://ift.tt/32p3n83
via IFTTT

InflaRx Shines On Data From Open Label Extension Part Of IFX-1 Study

Shares of InflaRx (IFRX) climbed more than 30% in extended trading on Wednesday, following positive results of the open-label extension part of the Company's international phase IIb study of IFX-1 in patients with moderate to severe Hidradenitis Suppurativa, dubbed SHINE.

from RTT - Biotech https://ift.tt/2NPTA5s
via IFTTT

Commerzbank Q3 Profit Rises; Expects FY19 Profit To Be Lower Than Prior Year

German lender Commerzbank AG (CRZBY.PK) reported that its consolidated profit for the third quarter grew 34.7 percent to 294 million euros from 218 million euros last year. Earnings per share increased to 0.23 euros from 0.17 euros in the prior-year period.

from RTT - Earnings https://ift.tt/2pQfPQH
via IFTTT

Yes, CNST Has Brightened Up Stock Portfolio - Did You Ride The Rally?

Shares of Constellation Pharmaceuticals Inc. (CNST) soared as much as 200% in intraday trading, touching an all-time high of $45.42 on Wednesday, as investors were delighted by the preliminary data on CPI-0610 in myelofibrosis published in abstracts by the American Society of Hematology.

from RTT - Biotech https://ift.tt/32q8ZPk
via IFTTT

Square, Inc. Q3 Profit Beats Estimates, Revenue Up 44%; Updates Guidance

Square, Inc. (SQ) reported adjusted net income per share of $0.25 for the third quarter of 2019, compared to $0.13, prior year. On average, 35 analysts polled by Thomson Reuters expected the company to report profit per share of $0.20, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA was $131 million in the third quarter of 2019, up 85 percent year over year.

from RTT - Earnings https://ift.tt/2CmZOo1
via IFTTT

Baidu App Traffic Up 25% In Sept.; Q3 Adj. Revenues Up 3%

Baidu, Inc. (BIDU) said Baidu App traffic continues to grow robustly with average daily active users or DAUs reaching 189 million, up 25 percent year over year, in September and Baidu's in-app search continues to gain market share. Baidu Smart Mini Program's monthly active users or MAUs, reached 290 million, up 157 percent year over year. iQIYI subscribers reached 105.8 million, up 31 percent year over year, in September 2019.

from RTT - Earnings https://ift.tt/33p5uKe
via IFTTT

Qualcomm Names Akash Palkhiwala CFO, Q4 Results Beat Street, Shares Up 5%

Qualcomm Inc. (QCOM) Wednesday announced the appointment of Akash Palkhiwala as executive vice president and chief financial officer.

from RTT - Earnings https://ift.tt/34D2l9W
via IFTTT

Traders May Remain Reluctant To Make Significant Moves

The major U.S. index futures are pointing to a slightly higher opening on Wednesday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2JWf7Iw
via IFTTT

Vulcan Materials Reaffirms FY19 Earnings Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, construction aggregates producer Vulcan Materials Co. (VMC) reaffirmed its earnings and adjusted EBITDA guidance for the full-year 2019.

from RTT - Earnings https://ift.tt/2JVzwxE
via IFTTT

Scotts Miracle-Gro Guides FY20 Adj. EPS In Line - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, Scotts Miracle-Gro Co. (SMG) initiated adjusted earnings and sales growth guidance for the full-year 2020, based on the continued strength of its two primary business segments.

from RTT - Earnings https://ift.tt/2JWRmQy
via IFTTT

Performance Food Group Q1 Profit Up 28%; Results Beat View - Quick Facts

Performance Food Group Co. (PFGC) on Wednesday reported that its net income for the first quarter of fiscal 2020 grew 28 percent to $36.1 million from $28.2 million in the year-ago period. Earnings per share rose 25.9 percent to $0.34 from $0.27 in the prior-year period.

from RTT - Earnings https://ift.tt/2Ck7BTK
via IFTTT

Wendy's Co. Boosts FY19, Backs FY20 Sales Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, The Wendy's Co. (WEN) raised its adjusted earnings and global systemwide sales growth guidance for the full-year 2019. The company also said it's on track to achieve new fiscal 2020 goals.

from RTT - Earnings https://ift.tt/34zsEgZ
via IFTTT

Black Knight Q3 Adj. Earnings Beat View, But Revenues Miss - Quick Facts

Black Knight, Inc. (BKI) on Wednesday reported that its net earnings for the third quarter decreased 13 percent to $37.3 million from $43.0 million in the prior-year quarter. Earnings per share declined 14 percent to $0.25 from $0.29 in the prior-year quarter.

from RTT - Earnings https://ift.tt/2ChlbXX
via IFTTT

Allete Q3 Profit Rises; Sees FY19 Earnings In Lower Half Of Outlook Range

Allete Inc. (ALE) on Wednesday reported third-quarter net income of $31.2 million or $0.60 per share, up from $30.7 million or $0.59 per share in the year-ago period, which included $1.7 million, $0.03 per share in earnings from U.S. Water Services sold in the first quarter of this year.

from RTT - Earnings https://ift.tt/2qphXyW
via IFTTT

Humana Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, health insurer Humana Inc. (HUM) raised its earnings and adjusted earnings guidance for the full year 2019.

from RTT - Earnings https://ift.tt/36FJr3S
via IFTTT

Lexington Realty Trust Q3 Profit Declines; Updates FY19 Outlook - Quick Facts

Lexington Realty Trust (LXP) on Wednesday reported that its third-quarter net income attributable to common shareholders was $141.6 million or $0.59 per share, down from $216.2 million or $0.90 per share last year.

from RTT - Earnings https://ift.tt/2NmshAL
via IFTTT

AES Reaffirms FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Wednesday, AES Corp. (AES) reaffirmed its adjusted earnings guidance for the full-year 2019, based on the strong third quarter and year-to-date results.

from RTT - Earnings https://ift.tt/2NouBr8
via IFTTT

BMW Q3 Profit Rises On Higher Volume; Backs Weak Profit View For FY19

German luxury carmaker BMW AG on Wednesday reported higher third-quarter profit with growth in deliveries. For fiscal 2019, the company continues to expect Group profit before tax to be significantly below the previous year's level. The company also projects a slight increase in the number of deliveries in the Automotive segment.

from RTT - Earnings https://ift.tt/2WPKLgk
via IFTTT

Keep An Eye On GRFS, FIVN, INGN.

What's moving these stocks?

from RTT - Earnings https://ift.tt/2WNzpcs
via IFTTT

Healthcare Stocks That Hit New Highs ( RETA, FLGT, HZNP,...)

The following are the healthcare stocks that hit a new 52-week high on Tuesday.

from RTT - Biotech https://ift.tt/2WOyZTp
via IFTTT

Marks & Spencer H1 Pre-tax Profit Rises; Says Market Conditions Challenging

Retailer Marks & Spencer Group Plc (MAKSY.PK, MAKSF.PK, MKS.L) reported Wednesday that its first-half profit before tax surged 51.5 percent to 153.5 million pounds from a restated 101.3 million pounds last year, reflecting lower net adjusting items in the period compared to the prior year. Basic earnings per share were 6.1 pence, up from 3.5 pence last year.

from RTT - Earnings https://ift.tt/2JTRCjr
via IFTTT